By Michele Maatouk
Date: Thursday 20 Jul 2023
LONDON (ShareCast) - (Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.
According to reports, Pfizer said the 250 acre site, with 1.4m square feet of manufacturing space, "is one of the largest sterile injectable facilities in the world".
Nearly 25% of all sterile injectables used in US hospitals are produced there.
Traders said that according to Bloomberg TV, the production that will be lost from the Pfizer plant can likely be replaced by Hikma, which produces the same injectables.
At 0920 BST, Hikma shares were up 7.7% at 2,101.68p.
Email this article to a friend
or share it with one of these popular networks:
Currency | US Dollars |
Share Price | $ 29.09 |
Change Today | $ 0.12 |
% Change | 0.41 % |
52 Week High | $33.94 |
52 Week Low | $25.26 |
Volume | 25,013,039 |
Shares Issued | 5,646m |
Market Cap | $164,242m |
Beta | 0.18 |
RiskGrade | 102 |
Strong Buy | 3 |
Buy | 6 |
Neutral | 15 |
Sell | 0 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
16:02 | 2,861,250 @ $29.09 |
15:59 | 174 @ $29.09 |
15:59 | 100 @ $29.09 |
15:59 | 100 @ $29.11 |
15:59 | 100 @ $29.11 |
You are here: research